Virtual Library

Start Your Search

  • ELCC 2018

    The 8th European Lung Cancer Conference

    Access to all presentations that took place at ELCC 2018 in Geneva, Switzerland

    Presentation Date(s):  
    • Apr 11 - 14, 2018
    • Total Presentations: 407

Filter Results:

Show Only Available Presentations

  • +

    Immunotherapy and next-generation TKIs: From second to frontline treatment

    • Type: Poster Discussion session
    • Presentations: 18
    • +

      138PD_PR - Patient-reported outcomes (PROs) in ALEX: A phase III study of alectinib (ALEC) vs crizotinib (CRIZ) in non-small-cell lung cancer (NSCLC)

      10:54 - 10:54  |  Presenter: M. Perol

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      139PD - Patient-reported outcomes from FLAURA: Osimertinib versus standard of care (SoC) epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) in patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC)

      10:54 - 10:54  |  Presenter: N. Leighl

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    Second line in non-oncogene addiction

    • Type: Educational session
    • Presentations: 5
    • Moderators:E. Garon
    • Coordinates: 4/12/2018, 09:00 - 10:30, Room B
    • +

      Chemotherapy combined with antiangiogenics: Which patients and when?

      09:00 - 09:20  |  Presenter: M. Garassino

      • Abstract

      No abstract available for this presentation

    • +

      Immunotherapy: Which patients and when?

      09:20 - 09:40  |  Presenter: E. Garon

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Hyperprogressive disease in second-line

      09:40 - 10:00  |  Presenter: B. Besse

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      New promising strategies in second-line

      10:00 - 10:20  |  Presenter: J. Remon-Masip

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Q&A

      10:20 - 10:30

      • Abstract

      No abstract available for this presentation

  • +

    How can we optimise our organisation to deliver precision oncology?

    • Type: Educational session
    • Presentations: 5
  • +

    New approaches in rare thoracic tumors

    • Type: Proffered Paper session
    • Presentations: 6
    • Moderators:M. Perol
    • Coordinates: 4/13/2018, 11:00 - 12:30, Room A
    • +

      213O - Nintedanib + pemetrexed/cisplatin in malignant pleural mesothelioma (MPM): Phase II biomarker data from the LUME Meso study

      11:40 - 11:55  |  Presenter: N. Pavlakis

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.